Lonza Announces Major Expansion of Bioconjugation Capabilities in Switzerland, adding 200 Jobs by 2028
Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, announced it will invest in additional bioconjugation capabilities in Visp (CH). The expansion will add two multipurpose 1,200L manufacturing suites and manufacturing-related infrastructure to the existing b…
